AHA Scientific Sessions 2025 Abstract
Single dose of a novel CRISPR-CasX editor potently reduces triglycerides in preclinical models and efficiently edits APOC3 in non-human primates
Experiments in animalsInterventions
The paper
Scribe therapeutics; Scribe Therapeutics
AHA Scientific Sessions 2025 Abstract, 3 Nov 2025
Presented at AHA Scientific Sessions 2025, abstract 4370295


